Effect of percutaneous acupoint electrical stimulation combined with NMDA receptor antagonist on pain after thoracoabdominal surgery under general anesthesia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006671

Enrollment

Unknown

Registered

2022-10-01

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

1:Sufentanil

2:esketamine

3:transcutanclus electrical acupoint stimulation

4:transcutanclus electrical acupoint stimulation+ intravenous injection of esketamine

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 85 years (including 18 and 85 years old); 2. American society of anesthesiologists (ASA) classification I, II, ?; 3. Elective patients undergoing major thoracic and abdominal surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Abnormal liver and kidney function before surgery (preoperative liver enzyme index or creatinine exceeds 1.5 times the upper limit of normal); 2. Heart failure, arrhythmia; 3. Morbid obesity; 4. Bronchial asthma, abnormal coagulation function, history of cerebrovascular accident, increased intracranial pressure, intracranial space-occupying lesions; 5. Patients who have been dependent on or allergic to analgesics and anesthetics in the past; 6. Those who cannot cooperate due to various reasons.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale;	—

Countries

China

Contacts

Public ContactQi Yu

qiyu1987xiaobao@163.com+86 17712988986

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026